Skip to content

The effect of methylene blue on microcirculation in patients with septic shock

The effect of methylene blue on microcirculation in patients with septic shock

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106063
Enrollment
Unknown
Registered
2025-07-16
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic shock

Interventions

Experimental group:Standard treatment and methylene blue at a loading dose of 2.0mg/kg +0.5mg/kg/h was maintained for 24 hours.
Control group:Standard treatment for spetic shock.

Sponsors

Mindong Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Diagnosed as septic shock based on of Sepsis-3 definition; 3.Patients who requiring a continuous infusion of norepinephrine greater than 0.5 ug/kg/min or an equivalent dose of other vasopressors to maintain mean arterial pressure (MAP) greater than 65 mmHg; 4.Patient or guardian has signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Patients allergic to methylene blue; 3.Glucose 6-phosphate dehydrogenase deficiency; 4.Patients participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Sublingual microcirculation;

Secondary

MeasureTime frame
Skin Mottling Score;Capillary Refill Time;Vasoactive drugs;Central venous oxygen saturation;Mean arterial pressure;

Countries

China

Contacts

Public ContactHuogen Lliu

Mindong Hospital of Fujian Medical University

437129519@qq.com+86 150 6026 3362

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026